Sublingual Ketamine Tablet Dosing: What the Ranges Mean

When a ketamine tablet is prescribed for sublingual use, the tablet is held under the tongue or against the inside of the cheek so the drug can absorb through the oral mucosa rather than being swallowed and processed by the liver. That route changes how much medication actually reaches the bloodstream, and it shapes the dose your prescriber chooses.

This article covers how sublingual tablet dosing differs from swallowed dosing, the ranges reported in published protocols, the technique that affects absorption, and the safety boundaries that apply at every dose level. The numbers reflect published off-label protocols and case series — not a recommendation for any individual.

Sublingual vs Swallowed: Why the Route Changes the Dose

Ketamine taken sublingually or buccally bypasses much of the first-pass metabolism that affects a swallowed tablet. Published bioavailability values for sublingual or oromucosal ketamine generally fall around 25 to 30 percent, while bioavailability for fully swallowed ketamine is typically lower, often around 15 to 25 percent. The clinical effect is that a sublingual milligram dose tends to behave like a somewhat larger swallowed dose, though individual variation is wide.

Because the swallowed fraction still contributes — saliva inevitably carries some drug down to the gut — sublingual tablets are best described as a mixed-route product. Holding time and technique determine how much of the dose acts via mucosal versus gastrointestinal absorption.

Typical Sublingual Tablet Dose Ranges

Published off-label protocols for sublingual ketamine in mood and pain indications typically report starting adult doses in the range of about 25 to 100 mg per session, corresponding to roughly 0.5 to 1.0 mg/kg in many adults. Some maintenance protocols use higher per-session doses with longer intervals between sessions, while pain protocols may use smaller doses more frequently.

Frequency in published series ranges from several times per week to every one or two weeks, with maintenance plans sometimes spacing doses out further. There is no single standard cadence; the prescribing clinician sets the schedule based on indication, response, and side effects.

How Technique Affects the Effective Dose

Two patients on the same prescribed milligram dose can absorb noticeably different amounts based on how the tablet is held in the mouth. The factors most often discussed in published guidance include holding time, swallowing pattern, and what is in the mouth before and after dosing.

Longer mucosal contact, slower swallowing of saliva, and an empty mouth before dosing all tend to favor mucosal absorption. Eating, drinking, or rinsing the mouth immediately after dosing can reduce the mucosal fraction and shift more of the dose toward the slower swallowed route.

Comparing Sublingual Tablets to Other Oral Forms

The sublingual tablet is one of several oral dosage forms used in compounded ketamine practice. Troches and lozenges are larger, slower-dissolving formats that also absorb through the oral mucosa. Capsules and rapidly swallowed tablets sit at the other end of the spectrum and behave more like a swallowed dose. The chart below summarizes typical published characteristics; ranges are illustrative and overlap considerably.

Step-by-Step: Taking a Sublingual Ketamine Tablet

If your prescriber has set you up for sublingual dosing, these steps reflect commonly recommended technique. Specific instructions from your clinician always take priority.

1. Confirm the dose and the holding time written on your prescription.
2. Set up your supervised, distraction-free setting before the dose.
3. Place the tablet under the tongue (or in the cheek pouch as instructed).
4. Let the tablet dissolve slowly; avoid chewing or swallowing it whole.
5. Hold the dissolved contents in the mouth for the full recommended time.
6. Spit out or swallow per your prescriber's instructions when the time ends.
7. Wait through the post-dose window before food, drink, or rinsing.
8. Log onset, peak, side effects, and recovery for the next visit.

Titration and Adjusting Sublingual Doses

Most published protocols start at the lower end of the dose range and titrate upward in small increments — often 25 to 50 mg per step — with at least one to several days between increases so the clinician can review response and side effects. Symptom tracking, blood pressure readings, and a record of the dissociation experience all inform the next step.

Dose increases continue until a useful response is reached, a side effect ceiling is hit, or a per-session limit is reached. Decreases are also common and can come from new side effects, new medications, or a change in the underlying condition.

Sublingual-Specific Cautions and Contraindications

All standard ketamine contraindications apply to sublingual tablets: uncontrolled hypertension, certain cardiovascular conditions, increased intracranial or intraocular pressure, active psychosis, current pregnancy, and a history of substance use disorder are general reasons to avoid or use ketamine cautiously. Sublingual dosing adds one more consideration — significant mouth pathology, recent oral surgery, or severe xerostomia can change how a tablet dissolves and how much drug reaches the mucosa.

Driving and operating machinery are not safe for several hours after a session because of dissociation, sedation, and impaired coordination. The exact window is set by the prescriber and depends on dose, response, and other medications.